Atlas Trials

This Project At LMU Looks At How Using AI 2nd Opinion Report to Analyze Retinal Eye Scans Impact Doctors' Decisions About Treatment for Patients with a Specific Eye Disease (nAMD)

Clinical trial NCT06817915 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06817915
Sponsor
Johannes Schiefelbein
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Neovascular Age-Related Macular Degeneration (nAMD)
Start date
2025-01-30
Primary completion
2026-01-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.